N/A
31-12月-69 19:00:00
15 分の遅延
株式
本日の幅
N/A - N/A
ISIN
ソース
Cboe
Ipsen, Université de Montréal and IRICoR broaden existing oncology partnership, with an exclusive license agreement and two new discovery-stage programs
15 2 2023 01:00:00 提供 Nasdaq GlobeNewswire
Cabometyx® in combination with nivolumab shows durable survival benefits at over three-years’ follow-up in first-line advanced renal cell carcinoma
13 2 2023 17:00:00 提供 Nasdaq GlobeNewswire
IPSEN: Monthly information relative to the total number of voting rights and shares composing the share capital
10 2 2023 12:00:00 提供 Nasdaq GlobeNewswire
Ipsen presents strong full-year 2022 results and guidance for 2023
09 2 2023 01:00:02 提供 Nasdaq GlobeNewswire